Overall, the percentage of human CD45+ immune cells in the tumor was low (Fig. 3B), and T cells represented the vast majority of the immune cells in the tumor (Fig. 3C) in the huNOG model; thus, we focused our analysis solely on the CD3+ population. The gene discussed is PTPRC; the disease is neoplasm.